Nytamel (Zolpidem Tartrate)

Zolpidem tartrate, the active ingredient in Nytmel, is a non‑B‑ hypnotic presented as a tablet for oral use. It is indicated for the short‑term treatment of insomnia in adults.

GNH USA supplies Nytmel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Nytmel is a short‑acting hypnotic that acts on the central nervous system to facilitate sleep onset. It is used in the following clinical situations: - Insomnia: Helps shorten the time to sleep and increase total sleep duration in adults with transient insomnia. - Pre‑operative sleep disturbances during hospital stays : Impro   y -   t  t